CompletedPhase 2NCT01986725
The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence
Studying Vulvar carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- St.Gallen University of Applied Sciences
- Principal Investigator
- Beate Senn, PhD, RNInstitute for Applied Nursing Sciences IPW, University of Applied Sciences FHS St. Gallen, Switzerland
- Intervention
- standardized care (Intervention I)(behavioral)
- Enrollment
- 45 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2013 – 2015
Study locations (1)
- Institute for Applied Nursing Sciences IPW, University of Applied Sciences FHS St. Gallen, Switzerland, Sankt Gallen, Switzerland
Collaborators
Insel Gruppe AG, University Hospital Bern · University Hospital, Basel, Switzerland · Cantonal Hospital of St. Gallen · Medical University of Vienna · Cantonal Hospital of Lucerne, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01986725 on ClinicalTrials.govOther trials for Vulvar carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06447064Cancer Loyalty Card Study 2 (CLOCS-2)Imperial College London
- RECRUITINGNCT07380698The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological CancerCukurova University
- ENROLLING BY INVITATIONNANCT07023601International Prospective Multicentre Study That Evaluate the Sentinel Lymph Node Detection Rate in Patients With First Local Recurrent Scamous Cell Carcinoma of the Vulva.Hospital Universitario La Paz
- RECRUITINGPHASE2NCT05903833Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or RadiotherapyAGO Research GmbH
- RECRUITINGNANCT05576831STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide ExcisionBritish Columbia Cancer Agency
- RECRUITINGNANCT06495554Danish Vulva Cancer Recurrence StudyUniversity of Aarhus
- RECRUITINGNANCT06264167NODE (groiN ultrasOunD cancEr)Queensland Centre for Gynaecological Cancer
- ACTIVE NOT RECRUITINGNANCT06694116Charcoal Carbon Black Dye Use in Sentinel Lymph Node Mapping in Early Stage Vulvar CancerIstanbul University